These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8658757)

  • 1. Optimal immunosuppressive regimen for hepatitis B-positive kidney transplant recipients.
    Hsieh H; Chen CH; Huang HF; Tseng YJ
    Transplant Proc; 1996 Jun; 28(3):1495-7. PubMed ID: 8658757
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver transplantation in hepatitis B surface antigen positive patients with postoperative long-term immunoprophylaxis.
    Langrehr JM; Lemmens HP; Keck H; Lohmann R; Knoop M; Neumann U; Müller AR; Platz KP; Kling N; Hopf U
    Transplant Proc; 1995 Feb; 27(1):1215-6. PubMed ID: 7533373
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppressive protocols at transplantation centers in Turkey.
    Haberal M; Demirağ A; Bilgin N; Arslan G; Büyükpamukçu N
    Transplant Proc; 1995 Oct; 27(5):2776-7. PubMed ID: 7482911
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of immunosuppressive therapy after renal transplantation: a randomized study.
    Heering P; Westhoff A; Ivens K; Kutkuhn B; Grabensee B
    Transplant Proc; 1994 Oct; 26(5):2530-2. PubMed ID: 7940778
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of donor hepatitis B antigenemia on renal allograft in hepatitis B recipients.
    Chen JB; Hsieh H; Hsu KT; Chen CH
    Transplant Proc; 1996 Jun; 28(3):1490-2. PubMed ID: 8658755
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal transplantation in hepatitis B surface antigen-positive patients: single-center experience in Korea.
    Kim YG; Kim S; Lee JH; Kim YK; Han JS; Lee JS; Kim SJ; Kim ST
    Transplant Proc; 1994 Aug; 26(4):2143-5. PubMed ID: 8066701
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased risk of rejection in cyclosporine monotherapy versus combined cyclosporine-steroid immunosuppression in young kidney recipients.
    Oppenheimer F; Cofán F; Flores R; Pais B; Ochs J; Ricart MJ; Vilardell J; Campistol JM; Torregrosa JV
    Transplant Proc; 1994 Oct; 26(5):2516-7. PubMed ID: 7940773
    [No Abstract]   [Full Text] [Related]  

  • 8. Results of kidney transplantation in HBsAG and anti-HCV seropositive renal allograft recipients.
    Durlik M; Gaciong Z; Soluch L; Rowińska D; Kozłowska-Boszko B; Rowiński W; Szmidt J; Lao M
    Transplant Proc; 1996 Dec; 28(6):3459-60. PubMed ID: 8962347
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term outcome of hepatitis B after renal transplantation during childhood.
    Gagnadoux MF; Guest G; Ronsse-Nussenzveig P; Mitsioni A; Broyer M
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1454-5. PubMed ID: 8442156
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
    Ahn HJ; Kim MS; Kim YS; Kim SI; Huh KH; Ju MK; Ahn SH; Han KH
    J Med Virol; 2007 Nov; 79(11):1655-63. PubMed ID: 17854044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten-year follow-up of kidney transplantation from hepatitis B surface antigen-positive donors.
    Sumethkul V; Ingsathit A; Jirasiritham S
    Transplant Proc; 2009; 41(1):213-5. PubMed ID: 19249516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression in kidney transplantation in Poland.
    Paczek L; Lao M; Durlik M; Szmidt J; Rowinski W
    Transplant Proc; 2004 Mar; 36(2 Suppl):173S-176S. PubMed ID: 15041331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal allograft function and results with cyclosporine immunosuppression in recipients of single kidneys from cadaveric donors aged 12 to 24 months.
    Banowsky LH; Wright FH; Kothmann R; Floyd M; Vick S
    Transplant Proc; 1996 Aug; 28(4):2121-4. PubMed ID: 8769175
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

  • 15. Living related donor kidney transplantation in patients with a positive flow cytometry crossmatch.
    Hong JH; Sadeghian M; Sumrani N; Distant DA; Sommer BG; Norin AJ
    Transplant Proc; 1996 Jun; 28(3):1614-5. PubMed ID: 8658808
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term survival in living related donor renal allograft recipients with hepatitis B infection.
    Roy DM; Thomas PP; Dakshinamurthy KV; Jacob CK; Shastry JC
    Transplantation; 1994 Jul; 58(1):118-9. PubMed ID: 8036701
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney transplantation from hepatitis B surface antigen (HBsAg)-positive donors: changes of relative HBV genomic copy number after transplantation.
    Lai MK; Chang KS; Chueh SC; Huang CC; Chen SC; Chu SH
    Transplant Proc; 1996 Jun; 28(3):1518-9. PubMed ID: 8658767
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation.
    Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin A; Stenzel KH
    Transplant Proc; 1996 Jun; 28(3):1309-10. PubMed ID: 8658672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.